Riveiro‐Barciela, M., Barreira‐Díaz, A., Esteban, P., Rota, R., Álvarez‐Navascúes, C., Pérez‐Medrano, I., . . . Londoño, M. (2024). Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver International, 44(9), 2303. https://doi.org/10.1111/liv.15970
Chicago Style (17th ed.) CitationRiveiro‐Barciela, Mar, et al. "Rituximab Is a Safe and Effective Alternative Treatment for Patients with Autoimmune Hepatitis: Results from the ColHai Registry." Liver International 44, no. 9 (2024): 2303. https://doi.org/10.1111/liv.15970.
MLA (9th ed.) CitationRiveiro‐Barciela, Mar, et al. "Rituximab Is a Safe and Effective Alternative Treatment for Patients with Autoimmune Hepatitis: Results from the ColHai Registry." Liver International, vol. 44, no. 9, 2024, p. 2303, https://doi.org/10.1111/liv.15970.